562 related articles for article (PubMed ID: 17035392)
1. Influence of patterns of hormone replacement therapy use and mammographic density on breast cancer detection.
Chiarelli AM; Kirsh VA; Klar NS; Shumak R; Jong R; Fishell E; Yaffe MJ; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1856-62. PubMed ID: 17035392
[TBL] [Abstract][Full Text] [Related]
2. Tumor characteristics associated with mammographic detection of breast cancer in the Ontario breast screening program.
Kirsh VA; Chiarelli AM; Edwards SA; O'Malley FP; Shumak RS; Yaffe MJ; Boyd NF
J Natl Cancer Inst; 2011 Jun; 103(12):942-50. PubMed ID: 21540443
[TBL] [Abstract][Full Text] [Related]
3. Case-control study of increased mammographic breast density response to hormone replacement therapy.
Vachon CM; Sellers TA; Vierkant RA; Wu FF; Brandt KR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1382-8. PubMed ID: 12433715
[TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy, percent mammographic density, and sensitivity of mammography.
Kavanagh AM; Cawson J; Byrnes GB; Giles GG; Marr G; Tong B; Gertig DM; Hopper JL
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1060-4. PubMed ID: 15894653
[TBL] [Abstract][Full Text] [Related]
5. Using mammographic density to improve breast cancer screening outcomes.
Kavanagh AM; Byrnes GB; Nickson C; Cawson JN; Giles GG; Hopper JL; Gertig DM; English DR
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2818-24. PubMed ID: 18843028
[TBL] [Abstract][Full Text] [Related]
6. Digital versus screen-film mammography: impact of mammographic density and hormone therapy on breast cancer detection.
Chiarelli AM; Prummel MV; Muradali D; Shumak RS; Majpruz V; Brown P; Jiang H; Done SJ; Yaffe MJ
Breast Cancer Res Treat; 2015 Nov; 154(2):377-87. PubMed ID: 26518019
[TBL] [Abstract][Full Text] [Related]
7. Risk factors and tumor characteristics of interval cancers by mammographic density.
Holm J; Humphreys K; Li J; Ploner A; Cheddad A; Eriksson M; Törnberg S; Hall P; Czene K
J Clin Oncol; 2015 Mar; 33(9):1030-7. PubMed ID: 25646195
[TBL] [Abstract][Full Text] [Related]
8. Hormone replacement therapy and accuracy of mammographic screening.
Kavanagh AM; Mitchell H; Giles GG
Lancet; 2000 Jan; 355(9200):270-4. PubMed ID: 10675074
[TBL] [Abstract][Full Text] [Related]
9. Hormone replacement therapy and mammographic screening outcomes in Western Australia.
Crouchley K; Wylie E; Khong E
J Med Screen; 2006; 13(2):93-7. PubMed ID: 16792833
[TBL] [Abstract][Full Text] [Related]
10. Are breast density and bone mineral density independent risk factors for breast cancer?
Kerlikowske K; Shepherd J; Creasman J; Tice JA; Ziv E; Cummings SR
J Natl Cancer Inst; 2005 Mar; 97(5):368-74. PubMed ID: 15741573
[TBL] [Abstract][Full Text] [Related]
11. Use of hormone therapy and risk of breast cancer detected at screening and between mammographic screens.
Hofvind S; Møller B; Thoresen S; Ursin G
Int J Cancer; 2006 Jun; 118(12):3112-7. PubMed ID: 16395702
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer: missed interval and screening-detected cancer at full-field digital mammography and screen-film mammography-- results from a retrospective review.
Hoff SR; Abrahamsen AL; Samset JH; Vigeland E; Klepp O; Hofvind S
Radiology; 2012 Aug; 264(2):378-86. PubMed ID: 22700555
[TBL] [Abstract][Full Text] [Related]
13. Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.
Tamimi RM; Byrne C; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2007 Aug; 99(15):1178-87. PubMed ID: 17652278
[TBL] [Abstract][Full Text] [Related]
14. Novel mammographic image features differentiate between interval and screen-detected breast cancer: a case-case study.
Strand F; Humphreys K; Cheddad A; Törnberg S; Azavedo E; Shepherd J; Hall P; Czene K
Breast Cancer Res; 2016 Oct; 18(1):100. PubMed ID: 27716311
[TBL] [Abstract][Full Text] [Related]
15. Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers.
Mandelson MT; Oestreicher N; Porter PL; White D; Finder CA; Taplin SH; White E
J Natl Cancer Inst; 2000 Jul; 92(13):1081-7. PubMed ID: 10880551
[TBL] [Abstract][Full Text] [Related]
16. Effect of estrogen and estrogen-progestin replacement regimens on mammographic breast parenchymal density.
Persson I; Thurfjell E; Holmberg L
J Clin Oncol; 1997 Oct; 15(10):3201-7. PubMed ID: 9336356
[TBL] [Abstract][Full Text] [Related]
17. Factors contributing to mammography failure in women aged 40-49 years.
Buist DS; Porter PL; Lehman C; Taplin SH; White E
J Natl Cancer Inst; 2004 Oct; 96(19):1432-40. PubMed ID: 15467032
[TBL] [Abstract][Full Text] [Related]
18. The effect of hormone replacement therapy on the sensitivity of screening mammograms.
Litherland JC; Stallard S; Hole D; Cordiner C
Clin Radiol; 1999 May; 54(5):285-8. PubMed ID: 10362232
[TBL] [Abstract][Full Text] [Related]
19. Mammographic density as a surrogate marker for the effects of hormone therapy on risk of breast cancer.
Boyd NF; Martin LJ; Li Q; Sun L; Chiarelli AM; Hislop G; Yaffe MJ; Minkin S
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):961-6. PubMed ID: 16702377
[TBL] [Abstract][Full Text] [Related]
20. Effects of hormone replacement therapy regimens on mammographic breast density: the role of progestins.
Topal NB; Ayhan S; Topal U; Bilgin T
J Obstet Gynaecol Res; 2006 Jun; 32(3):305-8. PubMed ID: 16764621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]